905291-20-5

Basic information

• Product Name: C₂₃H₃₃BrO₄
• Synonyms: C₂₃H₃₃BrO₄
• CAS NO: 905291-20-5
• Molecular Weight: 453.417
• Mol File: 905291-20-5.mol

Chemical Properties

• CAS DataBase Reference: C₂₃H₃₃BrO₄(CAS DataBase Reference)
• NIST Chemistry Reference: C₂₃H₃₃BrO₄(905291-20-5)
• EPA Substance Registry System: C₂₃H₃₃BrO₄(905291-20-5)

Safety Data

• Hazardous Substances Data: 905291-20-5(Hazardous Substances Data)

Upstream product

• 224048-24-2 (2ζ,4aS,8aS)-2,5,5,8a-Tetramethyl-3,4,4a,5,6,7,8,8a-octahydronaphthalen-1(2H)-one 
• 224048-12-8 (-)-(1'S,2'S,2R)-4-(2'-Hydroxy-2',6',6'-trimethylcyclohexyl)-2-methylbutanoic acid 
• 109765-52-8 3-bromo-2-hydroxy-4,5-dimethoxybenzaldehyde 
• 91547-50-1 (4aS,8aS)-5,5,8a-trimethylhexahydro-2H-spiro[naphthalene-1,2'-[1,3]dioxolan]-6(5H)-one 
• 41722-49-0 (S)-1,4a-dimethyl-4,4a,7,8-tetrahydronaphthalene-2,5(3H,6H)-dione 
• 57440-68-3 2-methyl-2-(3-oxopentyl)-1,3-cyclohexanedione 
• 14382-91-3 2-hydroxy-4,5-dimethoxybenzaldehyde 
• 20404-65-3 (-)-(2R,4aS,8aS)-2,5,5,8a-Tetramethyl-3,4,4a,5,6,7,8,8a-octahydronaphthalen-1(2H)-one 
• 60134-39-6 (-)-(4aS,8aS)-3,4,4a,5,6,7,8,8a-octahydro-5,5,8a-trimethylnaphthalen-1(2H)-one 
• 4460-86-0 asaraldehyde 
• 91547-54-5 (4aS,8aS)-3,4,4a,5,6,7,8,8a-Octahydro-5,5,8a-trimethylnaphthalen-1(2H)-one ethylene acetal 
• 1193-55-1 2-methylcyclohexane-1,3-dione 
• 26742-33-6 (4aS)-1,4aβ-dimethyl-4,4a,7,8-tetrahydronaphthalene-2,5(3H,6H)-dione-5-ethyeneacetal 
• 874194-38-4 [3-bromo-2-(tert-butyl-dimethyl-silanyloxy)-4,5-dimethoxy-phenyl]-methanol 

Downstream Products

• 905291-32-9 C₂₃H₃₁BrO₃ 
• 905291-26-1 C₂₃H₃₁BrO₃ 
• 905291-34-1 C₂₃H₃₁BrO₃ 

Relevant articles and documents

Synthesis of phosphatidylinositol 3-kinase (PI3K) inhibitory analogues of the sponge meroterpenoid liphagal

Analogues of the sponge meroterpenoid liphagal (1) have been synthesized and evaluated for inhibition of PI3Kα and PI3Kα as part of a program aimed at developing new isoform-selective PI3K inhibitors. One of the analogues, compound 24, with IC50/sub

MEROTERPENOID INHIBITORS OF PHOSPHOINOSITIDE 3 KINASE (PI3K)

Compounds with unique liphagane meroterpenoid carbon skeleton are described (structures I, II, III) together with pharmaceutical compositions and their use. A method of inhibiting the activity of phosphoinositide 3 kinase (PBK) is disclosed. In particular